clinical_trials
STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
Confidence88·multiple reportsImportance90NP-EVT-20261023-A15211E
An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.
Read the original at the primary source
STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer
Adam Feuerstein · 10/23/2026, 10:30:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —